Coming Soon

PREVIOUS
Learn about the Interactive Case Studies and method
of administration for IMFINZI

SEE INTERACTIVE CASE STUDIES
patients_profile
patients_profile
posology
posology

NEXT
There is an unmet need for patients with Stage III NSCLC1,2
LEARN MORE ABOUT NSCLC

CBC: complete blood count; COPD: chronic obstructive pulmonary disease; CRT: chemoradiation therapy; ECOG: Eastern Cooperative Oncology Group; FEV1: forced expiratory volume in one second; LABA: long-acting beta-agonist; LFT: liver function test; NSCLC: non-small cell lung cancer; PFT: pulmonary function test; WHO: World Health Organization

Reference: 1. Draft IMFINZI Summary of Product Characteristics. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2018. 

 

Loading......

References: 1. Postmus PE, Kerr KM, Oudkerk M, et al; ESMO Guidelines Committee. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl 4):iv1-iv21. 2. Hanna N. Current Standards and Clinical Trials in Systemic Therapy for Stage III Lung Cancer: What Is New? Am Soc Clin Oncol Educ Book. 2015:e442-e447.